Philippe A Bilodeau
Neurology — Massachusetts General Hospital, United States
Philippe A. Bilodeau
LeadR Profile
Neurology
Subspecialties: Immunology - Biochemistry - Infectiology
Main Topics
Publications and Clinical Studies
Profile data updated on
Expert Rankings
Top experts on the MeSH terms this expert works on
Organizations
Career arc: 2016 - 2026
Number : 52
Citations
Main journals
Best Journals
Breakdown by type
Click a legend label to hide or show it in the chart.
Latest Publications
5 most recent indexed articles
Source: Pubmed
| Title | Journal | Year | Citations |
|---|---|---|---|
| MOG Antibody in Pregnancy and Breast Milk: An Analysis of 2 Case Reports. milk, human, pregnancy, milk, breast | Neurol Neuroimmunol Neuroinflamm | 2026 | 0 |
| Effectiveness and Safety of Plasmapheresis in MOGAD Attacks: A Systematic Review and Meta-Analysis. safety, myelitis, neuritis, recycling, plasmapheresis, optic neuritis, visual acuity, therapeutics, neurology | Neurology | 2026 | 1 |
| CD4 + T cells reactive to Epstein-Barr virus late lytic antigens are enriched in individuals with multiple sclerosis. cells, sclerosis, multiple sclerosis, herpesvirus 4, human, viruses, therapeutics | Sci Transl Med | 2026 | 7 |
| Interleukin 6 Receptor Blockade for Relapse Prevention in Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease. oligodendroglia, safety, myelin-oligodendrocyte glycoprotein, receptors, interleukin-6, incidence, interleukin-6, glycoproteins, therapeutics, nervous system diseases, infections, immunoglobulins, intravenous | JAMA Neurol | 2026 | 4 |
| IL-6 Receptor Blockade as Rescue Therapy in Acute Attacks of MOGAD and AQP4+NMOSD. receptors, interleukin-6, interleukin-6, therapeutics, nervous system diseases | JAMA Neurol | 2026 | 0 |
LeadR Networks
Main global connection map